Israel will sign a preliminary contract with Pfizer Inc. on Friday to receive 8 million doses of the drugmaker’s still-experimental coronavirus vaccine from January, the Israeli health minister said.
The deal, which must be approved by the U.S. Food and Drug Administration (FDA) and the Israeli Ministry of Health, would provide vaccines for nearly half of Israel’s population, Health Secretary Yuli Edelstein said.
“Delivery would start in January 2021, with the rest arriving later in 2021,” he said in a statement Thursday, adding that the order would be 8 million cans, enough for 4 million people.
Pfizer and its partner BioNTech SE confirmed the deal in a statement Thursday, saying they would not disclose financial details, but the terms of the contract would be tied to the time of delivery and the volume of cans provided.
“Our goal remains to create a global supply of a safe and effective COVID-19 vaccine to many people around the world as soon as possible,” said Sean Marett, chief business officer at BioNTech, in a statement.
Pfizer announced on Monday that its experimental COVID-19 vaccine was more than 90% effective based on initial trial results. This was a major victory in the war against a virus that killed over a million people and affected the global economy.
A Pfizer spokesman said the final signing would take place on Friday.
(Except for the headline, this story was not edited by GossipMantri staff and posted from a syndicated feed.)